AI-generated summary
The authors report a randomized controlled trial of 30 adults with hematologic malignancies who underwent stem cell transplantation, comparing low-level laser photobiomodulation with standard care. Severe oral mucositis was reported in 26.6% of controls and 0% of the photobiomodulation group, but physical function and quality of life did not differ significantly between groups.
- Participants
- 30
- Who or what was studied
- Adults with hematologic malignancies who underwent hematopoietic cell transplantation (Chilean context)
- Wavelengths
- 660, 808 nm
- Limits stated in the abstract
- The abstract reports a small sample of 30 patients, and the analyzed group of 15 participants per arm is not clearly explained.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 808 nm
- Power
- 100 mW
- Total energy
- 2 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Oral mucositis, Photobiomodulation, Trial registration, Control group, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.